Story Poster
Photo by Matt Freeman
Notre Dame Baseball

Game Thread | (G1) Notre Dame at No. 22 Boston College

May 18, 2023

Notre Dame (29-20, 14-13) vs. No. 22 Boston College (32-16, 14-13)

When: May 18th

Time: 5:30 PM ET 

Where: Eddie Pellagrini Diamond | Brighton, Mass. 

Watch: ACC Network Extra 


- Notre Dame leads the overall series 37-19. 

- The Irish are 15-9 at Boston College and 7-5 at neutral sites. 

- Game two will be played at Fenway Park as part of Boston College’s 11th Annual ALS Awareness Game.

- Notre Dame is projected as a No. 3 seed in the Morgantown Regional in D1Baseball’s latest Field of 64 projection. 


Notre Dame LHP Aidan Tyrell 7-2 2.87 59.2 51
Boston College RHP Henry Leake 3-4 6.66 52.2 55


Notre Dame RHP Blake Hely 3-2 4.77 66.0 69
Boston College RHP Chris Flynn 6-2 3.96 63.2 74


Notre Dame TBD - - - -
Boston College TBD - - - -

OFFENSIVE STATS (Entering the series)

STAT Boston College Notre Dame
Batting Avg. .273 .246
Runs 318 284
Hits 448 400
2B 80 69
3B 4 9
Home Runs 57 58
RBI 289 257
SLG% .430 .407
Walks 254 191
Hit by Pitch 70 85
Strikeouts 402 426
OB% 0.387 0.353

PITCHING STATS (Entering the series) 

STAT Boston College Notre Dame
ERA 5.51 4.41
Hits 470 397
Runs 276 244
ER 261 212
Walks 169 185
Strikeouts 446 412
Opponent Batting Avg. .281 .242

- It’s the final regular season series of the year and it’s an important one for Notre Dame. The latest D1Baseball Field of 64 projection has the Irish as a No. 3 seed, but a series win could be a statement for Notre Dame as Boston College enters the weekend ranked No. 22 in the country. 

That said, Notre Dame has similar data points to several other ACC programs that made the NCAA Tournament with a .500 conference record. That .500 mark in the ACC seems like the cut-off between making and missing the tourney, but Notre Dame can make it easy and win two games this weekend. 

- There isn’t anything ground-breaking heading into the series with Boston College. Notre Dame needs to hit, move runners and score runs. The Eagles pitching staff isn’t electric and teams are hitting .281, so there will be opportunities for the inconsistent Irish offense. 

With third baseman Jack Penney out, it will be interesting to see what Shawn Stiffler does as he moved second baseman Estevan Moreno to third and inserted Connor Hincks at second late in Tuesday’s game against Northwestern. Moreno had worked at third during fall ball, so there is a familiarity there. Hincks transferred from Virginia and has played in just seven games, but Casey Kmet (.167) and Nick DeMarco (.065) have struggled at the plate for most of the year and they were the first out of the dugout to replace Penney last weekend. 

- LHP Aidan Tyrell will get the nod on Thursday and he’s been consistent for much of the year. Tyrell sits at a 2.87 ERA in 59.2 innings and he’s coming off a season-high seven strikeouts against Akron last weekend. The graduate student has given up hits lately, but limited the runs for the most part. 

Notre Dame’s relief pitching will be an interesting study this weekend. The Irish have to win at least one game, so will Stiffler use Caden Spivey and the big guns on Thursday if it’s a close game or stick to his normal rotation? 

LHP Will Mercer had to be used in Tuesday’s loss vs. Northwestern, so he probably won’t throw until Friday at the earliest. 

Overall, huge weekend for Notre Dame baseball as it relates to postseason play, but also the Irish will play at Fenway Park. 

Notre Dame Lineup

TJ Williams CF .236
Zack Prajzner SS .300
Carter Putz 1B .281
Vinny Martinez C .301
Brooks Coetzee RF .266
DM Jefferson DH .255
Brady Gumpf LF .250
Casey Kmet 3B .167
Estevan Moreno 2B .208

Boston College Lineup

Barry Walsh CF .310
Peter Burns C .246
Patrick Roche RF .290
Joe Vetrano 1B .295
Vince Cimini 2B .284
Nick Wang 3B .246
Parker Landwehr DH .125
Sam McNulty SS .340
Cohl Mercado LF .262

Notre Dame Fighting Irish Play Like A Champion Today Tri-Blend Raglan Long Sleeve T-Shirt


subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.